The rise, acceleration and acceptance of telehealth adoption
In our latest article for pharmaphorum Deep Dive, Marietta Fernandes, uses findings from our Digital Health Trends survey to summarise what we have learned about the rise of digital health tools since the start of the global pandemic.
Live from Singapore. Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy
In this webinar on 24th February 2022 we will investigate changes in HCP and patients' online behaviours and share market research techniques to help build an effective omnichannel strategy and enhance digital engagement.
The Market Research Society has published its annual League Tables and Research Partnership ranks 7th in the top 20 fastest-growing businesses and 12th in the top 20 fastest-growing individual agencies.
Research Partnership makes 7 senior promotions and welcomes 2 new apprentices to its workforce
Research Partnership is delighted to announce a number of promotions in our UK and US offices, with 7 Associate Directors being promoted to Directors. We have also had the pleasure of welcoming 2 Project Management Apprentices who recently joined our UK office.
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape look like?
How we helped to inform the market access strategy for a new CAR-T therapy in multiple myeloma
Our client was developing a CAR-T therapy in Multiple Myeloma (MM) across multiple lines of therapy. Find out how we informed their market access strategy by identifying the key value drivers and optimal clinical trial design
How we assessed demand and competition for a novel digital implantable therapeutic
Our client wanted to prepare a US forecast by demonstrating demand under specific clinical profiles for their implant product in the treatment of diabetes, identify the commercial contingencies and assumptions versus a competitor with an alternative method of administration.
How we assessed the ongoing market opportunity for a digital health solution
Our client wanted to validate if their digital tool, which combined various features including a diagnostic element, delivered as an App, was still a good commercial fit compared with alternative options, looking at multiple therapy areas and various emerging markets.
Breaking the silence: It’s time to talk about the menopause
October is World Menopause Awareness Month. In our latest article for PM Live, Vicki Newlove uses findings from our latest opinion poll to outline why the hidden landscape of menopause may finally be starting to change.
Omnichannel marketing: the new template for customer engagement
Our experts discuss why pharma companies need to embrace creative thinking in response to new patterns of demand and create marketing strategies fit for a digitally enabled, consumer-oriented landscape.
The Living with team is attending the Patient Centricity and Engagement Conference 2021
We are delighted to be sponsoring and exhibiting at the conference on 9th September. Representing Research Partnership at the event will be Head of Living With, Mariel Metcalfe and Business Development Executive, Andie Vinycomb.
How to embrace behavioural science principles in healthcare MR
Behavioural science is the scientific, evidence-based study of human behaviour in order to influence desired changes. Based on our expertise and experience, we have put together a guide on how to embrace behavioural science principles in healthcare market esearch.
We’re delighted to announce that a study carried out on behalf of Janssen Pharmaceuticals was selected by the American Society of Clinical Oncology for an e-poster presentation at the ASCO Annual Meeting in June 2021
We were delighted that a Research Partnership study into the burden of illness in newly diagnosed Multiple Myeloma patients & their caregivers was selected for an e-poster presentation at the EHA 2021 Virtual Congress.
How to improve payer engagement with tailored value communication
In this article for pharmaphorum, Cecilie Alstad, Senior Analyst, discusses how an approach established in the world of marketing and commercial strategy could be the key to significantly improving pharma’s payer engagement.
We’re delighted to announce a Research Partnership study into the burden of illness in newly diagnosed Multiple Myeloma patients & their caregivers has been selected for an e-poster presentation at the EHA 2021 Virtual Congress.
An-hwa Lee, Director, will be co-presenting ‘Finding a focus for telemedicine: Visionary patient opportunity or short-sighted solution?’ with Karen Sheehan, Insights and Analytics Business Partner at Novartis
In this webcast, quantitative experts Rebecca Davies and Richard Newman, will utilise their knowledge and experience of conducting global segmentations for pharma, to explore a range key segmentation challenges.
Influencing HCP behaviours – Is now the perfect opportunity?
In this webcast, our behavioural science Directors, Dan Coffin and Anthony Greenwood, demonstrate how to put behavioural science at the forefront of market research and deliver insights that drive demonstrable impact on physician and patient behaviour during this time of great change.
Research Partnership and Bristol Myers Squibb are 2021 BOBI Award finalists
We are excited to announce that two of Research Partnership’s submissions for this year’s BOBI Awards have been highly commended in both the ‘Best Patient-Centric Approach’ and ‘Analyst Team of the Year’ categories.
World EPA (Evidence, Pricing & Access) Congress 2021 round-up
Earlier this month several members of Research Partnerships Market Access team, including Directors Brett Gardiner and Rachel Howard, joined over 1000 global delegates attending the virtual World EPA Congress.
Chronic Venous Diseases patient journey 2020: Servier publishes key findings of a global market research study conducted by Research Partnership
A major survey carried out in five key representative countries (Brazil, China, Czech Republic, Italy and Russia) has recently been published on Servier’s website with the aim of supporting people with Chronic Venous Diseases (CVD).
COVID-19 vaccine pricing post pandemic - Payers' expectations
Rachel Howard and Suzan Serip outline why “In pandemic” pricing has not followed the usual market mechanisms for vaccine pricing and how payers expect vaccine prices to evolve once we emerge from the current crisis.
Agility happens when there is fluid and effective collaboration between researcher and client. Based on our expertise and experience, we have put together a guide on how to conduct effective agile research.
How we adapted our conference research to a virtual setting to measure performance and reactions
Our client was presenting clinical trial data for their cardiovascular product and were also exhibiting a virtual booth at the ESC (European Society of Cardiology) Congress 2020 – The digital Experience.
World Pharma Pricing Market Access & Evidence Congress 2020
Last month, several members of Research Partnership’s specialist market access team, including Directors Brett Gardiner and Rachel Howard, attended the virtual World Pharma Pricing Market Access & Evidence Congress.
UX research enables companies to understand user behaviours, needs and motivations for engaging with digital assets through observation techniques and task analysis. This guide shows you how to get the insights you need to allow you to improve the user experience.
How we helped our client maximise uptake and fine-tune the marketing strategy for their vaccine product in China
Our client’s vaccine to protect against a condition prevalent in older adults had recently launched, they wanted to understand more about their target healthcare consumer and attitudes to health, well-being and vaccination.
How we supported forecasting for a new vaccine by identifying the optimal pricing strategy
Our client was looking to identify the price point that would maximise revenue from their new vaccine across 8 emerging markets in Latin America and Asia Pacific, as well as establish long-term projections for their forecasting model.
How we conducted rare disease patient research during the COVID-19 lockdown in China
Our client needed to conduct a small number of qualitative interviews in China with patients diagnosed with a rare condition which affects children and young adults. The results of the survey were time critical as they were needed to inform a protocol being published in 30 working days.
How to create a market research programme for an effective product launch
This simple guide is aimed at helping companies who don’t have their own in-house research team. It outlines the key steps to creating a programme of research which will deliver the crucial insights for an effective marketing launch strategy.
How we used online bulletin boards and an advisory board to help our client understand the dynamics of the payer environment
Our client had a product for the treatment and prophylaxis of bleeding in patients with Haemophilia A. Although the market had been stable, it was expected to change somewhat significantly as new products were due to be launched.
Earlier this month Director, Head of NY Office, Liza Pliss and Director, Head of Philadelphia Office, Head of MedTech Division, Sabera Hyderally attended the Pharmaceutical Market Research Conference in Newark, New Jersey.
How we used WhatsApp and projective exercises to capture deep emotional insights into people living with HIV in South Africa
Our client wanted to identify and profile different segments of people living with HIV in order to understand key barriers and leverage points and ensure future engagement with their pharmaceutical portfolio.
Research Partnership welcomes new hires in our UK headquarters
Rebeca Nana Barrantes has joined the Market Access team as an Analyst. Alicia Crawley joined as Research Executive. Cristina Cunat Fernandez also joined the UK office as Quantitative Research Executive.
How we used Conference Live at a series of large and small-scale congresses to measure shifts in customer perceptions over time
Our client planned to have a significant presence at a variety of large and small-scale medical congresses in both the US and EU in support of their portfolio of products for a range of degenerative neurological conditions.
How a mindset-based customer segmentation was developed to drive engagement with physicians in oncology
Our client wished to develop an attitudinal mindset-based customer segmentation. This would allow for clear identification of each segment in the field; effective deployment of the sales force at launch by prioritising segments that show the greatest opportunity.
Like, like, like: Harnessing the power of social media insights
Given the colossal amount of personal and professional information that we share online, social media channels such as Facebook and Twitter are fast becoming treasure troves of big data. Harrison Gaiger explores how pharmaceutical companies can utilise social media insights.
How a combined qual quant approach provided our client with integral insights for continued product development in the HIV space
Our client was looking to develop novel HIV prevention products, and wanted to explore different formulation options. They wanted to learn both the reactions to the novel formulations as well as the impact of out-of-pocket (OOP) costs.
Andrew has 19 years of healthcare market research experience and joined Research Partnership as a graduate in 2000. Over the years he has made a significant contribution to the success of the company, both from a research perspective and in terms of providing management and leadership support.
Fast and furious - What will the fast tracking of approvals for key drugs mean for China's pharma market?
Expanded access to state-funded healthcare, population aging and a growing burden of chronic disease are creating new opportunities. Pei Li Teh asks, What will the fast tracking of approvals for key drugs mean for China's pharma market?
Richard Head presented with award at EphMRA Conference
Research Partnership exhibit, sponsor and present three papers at the EphMRA conference where Director Richard Head was presented with the runner-up award for ‘Business Impact through Innovation’ 2019.
How patient insights were brought to life with graphic novel outputs
Our client was developing a novel therapy for the treatment of a rare disease in which patients suffer acute symptomatic attacks, they requested that insights from the research, particularly patient research, were brought to life in the insights workshop meeting in a new and impactful way.
How Paediatricians and GPs revealed key insights to help develop a science story for a child nutritional supplement
Our client wanted to define the patient target, frame the challenge of growth delays to be an effective call to action, articulate objectives for the product and the best way to express its value proposition.
World Immunisation Week: Combating the rise of the anti-vaccination movement
Harrison Gaiger explores the rise of the anti-vaccination movement to understand what it has meant for global health, and outlines some of the initiatives that are aiming to combat vaccination hesitancy.
Friday 8th March 2019 marks International Women's Day, a global day of action aimed at accelerating gender equality and improving women's health. Asia-Pacific Director Pei Li Teh reflects on why this is such an important issue in emerging markets.
How to conduct research for scientific publication
Based on our expertise and experience of conducting market research for scientific publication in both developed and emerging markets across a wide range of therapy areas, we have put together a guide on how to establish medical credibility with your research.
How conference research was used to gauge reactions to new clinical data
Our client had recently conducted a series of clinical trials with its breakthrough cardiovascular product, resulting in outcomes data which had the potential to give it a more competitive edge and successfully differentiate it against their closest competitor.
Janssen & Research Partnership win prestigious BHBIA Best Business Impact award
Janssen and Research Partnership win the 2018 BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference for our collaborative market research and consultancy work.
How published research underpinned a cancer therapy awareness campaign
Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both patients and physicians across Asia.
How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy
Our client wanted to quantify how ovarian cancer patients are managed prior to product launch, but also needed to understand why patients do or do not receive key diagnostic tests or therapies. Time constraints limited the ability for a full qualitative phase.
How research supported the design of a support console to drive new product uptake
Our client wanted to discover physicians’ suggestions for the current prototype console and the potential barriers and drivers that may affect uptake, prior to initiating full development of the system.
How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market
Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led by established 1st generation tyrosine kinase inhibitors (TKIs).
How we evaluated the patient value for a new insulin pen
Our client markets a range of pen devices to deliver insulin to diabetes patients. They had developed a new feature for one of their current devices and wished to evaluate the utility of this feature to help understand if further refinement and development was required.
How facial analysis was used to evaluate the emotional impact of a disease promotion campaign
Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. They wished to understand physicians’ reactions to the campaign (rational and emotional).
Rachel Howard discusses the opportunities in the markets of Mexico, Indonesia, Nigeria and Turkey. These are the countries poised for strong economic growth, like the emerging markets of BRIC (Brazil, Russia, India and China) before them.
The value of design thinking: Incorporating creative and graphic design into pharma market research
How do we keep research design fresh and interesting? How do we ensure that we’re inspiring our respondents to give us enlightening new insights, and encourage new ways of thinking? This blog explores.
How brainstorming exercises enhanced a segmentation validation study
Our client had an oncology product in development for the treatment of prostate cancer, they wanted to conduct research to inform future planning, list development, advisory board creation, and initial communications platforms.
How conjoint was used to determine the optimum features for a BGM device
Our client wanted to determine the optimal new blood glucose monitoring device – one that would best retain their current customers and also attract new ones. They also wanted to be able to rationalise the strengths of their existing portfolio against their competitors.
In this article we look at South Korea’s healthcare outlook in more detail, and ask why the country lies at the extremes of two conflicting global health indicators – longest life expectancy and highest suicide rates.
How statistical analysis revealed the most effective segmentation solution for an established product in multiple indications
Our client has an established product for multiple indications. They wanted to create a HCP segmentation typing tool which could be implemented in-field to help classify physicians across two different therapeutic areas.
How wargaming was used to understand the likely future HCV landscape and give strategies for brand success
Our client wanted to conduct research in order to feed into strategy development for their product and find out what would physicians think of the new entrants and how could this be leveraged to ensure a successful launch.
How gamification and advanced analytics gave big pharma the insights to optimise their global corporate image
Our client’s senior management wanted to assess its company’s image amongst their key HCP stakeholders. The client wanted to measure familiarity and perceptions of the company versus its competitors, particularly in light of recent corporate announcements.
Access and elimination: the future of DAAs in Hepatitis C
Associate Director, Conor O’Kane, analyses data collected by Therapy Watch HCV, an online study of patient record forms collected each quarter from 335 physicians across nine European markets and Canada.
How qualitative insights were used to help shift perceptions of the use of probiotics in IBS Management
Our client wanted to uncover potential leverage points to build a strong storyline and communication strategy for their product, which would encourage healthcare professionals to recommend its use to their patients.
How qualitative research was used with payers in low and middle income countries for an Acute Heart Failure (AHF) drug
Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in low and middle income countries where patients self-pay for healthcare.
How market research data was used as a PR tool to help advocate for the healthcare benefits of vaccination
Our client wanted to understand why uptake of HPV vaccination in the Asia-Pacific region was limited. In order to help increase uptake, they wanted to publish the market research findings in journals to inform the public and medical community of the benefits of HPV vaccination.
Understanding Patient Willingness to Pay in Emerging Markets
In this webcast we explore the key features of self-pay markets and outline the critical success factors for determining how pharmaceutical, consumer health products and medical devices should be priced.
How we used a journey to the future to shape the salesforce strategy
Our client was developing a portfolio of innovative treatments and was in the process of recruiting a sales force to support the promotion of this portfolio. They wanted to understand the evolving customer expectations from their sales force within this dynamic environment.
How demand assessment techniques were used to evaluate the market landscape and product opportunity
Our client needed to understand more about the US and German market landscape in moderate-severe atopic dermatitis and how these advanced treatments might fit into the treatment algorithim when they are launched.
Based on our expertise and experience of conducting patient journey research in both developed and emerging markets across a wide range of therapy areas, we have put together a best practice guide based on our multi-stakeholder approach.
How to conduct effective pharma market research in rare diseases
Drawing upon our considerable experience of managing both small and large scale studies across a number of different diseases, we have created a guide outlining the key steps required to implement an effective market research programme.
Research Partnership Director Richard Head and Janssen Senior Market Research Manager, Stewart West, presented the paper “i Marks the Spot – how an innovative mobile methodology dug up hidden insights into patient compliance”
How we assessed HCP/ Patient communication in a real-life setting
Our client had a new adherence tool to be launched in the Auto-immune market. They wanted to analyse what impact it would have on HCP/ Patient communication in a real-life setting in order to inform their marketing strategy.
How conjoint was used to determine the optimum pricing strategy for a range of surgical products
Our client wanted to understand the value and price that healthcare providers attribute to a range of surgical products and to develop an effective pricing strategy for two new products with a unique mechanism of action.
Registered in England & Wales No. 3350410 as the Research Partnership Limited Registered office: 2nd Floor, 168 Shoreditch High Street, London, E1 6RA Directors: Mary Assimakopoulos, Mark Jeffery VAT No. GB 714 0707 65